Date
Location
Name of the organisation
Other participants (organisations)
Topics discussed Ref. Ares(2018)2575375 - 17/05/2018
27/01/2016 Teleconference
EFPIA
IMI2 Joint Undertaking Programme
Negotiation meeting for the IMI2 JU Annotated Model Grant Agreement, and
Office
the guidelines on reporting in-kind contributions
1/02/2016 EFPIA
EFPIA
IMI2 Joint Undertaking Programme
Meeting on the valuation of existing data for IMI2 JU projects
Headquarters,
Office
Brussels
2/02/2016 Teleconference
EFPIA, Johnson & Johnson, IMI2 Joint Undertaking Programme
Preparatory meeting for the IMI2 JU workshop on paediatric clinical research of
Bayer, Lilly, Novonordisk
Office
5 April 2016
4/02/2016 Teleconference
EFPIA
IMI2 Joint Undertaking Programme
Negotiation meeting for the IMI2 JU Annotated Model Grant Agreement, and
Office
the guidelines on reporting in-kind contributions
5/02/2016 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
Preparatory meeting of the IMI2 JU Governing Board of 22 March 2016
Undertaking
Office
Programme
Office, Brussels
8/02/2016 Teleconference
EFPIA, Johnson & Johnson, IMI2 Joint Undertaking Programme
Preparatory meeting for the IMI2 JU workshop on paediatric research of 5 April
Bayer, Lilly, Novonordisk
Office
2016
15/02/2016 Teleconference
EFPIA, Johnson & Johnson, IMI2 Joint Undertaking Programme
Preparatory meeting for the IMI2 JU workshop on paediatric clinical research of
Bayer, Lilly, Novonordisk
Office
5 April 2016
16/02/2016 Teleconference
EFPIA
IMI2 Joint Undertaking Programme
Preparatory meeting for the IMI2 JU strategy on patient engagement
Office
22/02/2016 Stanhope Hotel,
EFPIA
IMI2 Joint Undertaking Programme
Informal meeting of the IMI2 JU Governing Board
Brussels
Office
23/02/2016 Teleconference
EFPIA, Johnson & Johnson, IMI2 Joint Undertaking Programme
Preparatory meeting for the IMI2 JU workshop on paediatric clinical research of
Bayer, Lilly, Novonordisk
Office
5 April 2016
24/02/2016 European
EFPIA
Members of the European
Lunch debate: How IMI is accelerating access to affordable innovative medicines
Parliament,
Parliament; IMI2 Joint Undertaking
- hosted by MEP Françoise Grossetête
Brussels
Programme Office; Stockholm School
of Economics; UK National Institute
for Health and Clinical Excellence;
plus many other invited
organisations
Page 1 of 15
Date
Location
Name of the organisation
Other participants (organisations)
Topics discussed
25/02/2016 EFPIA
EFPIA
IMI2 Joint Undertaking Programme
Meeting on the valuation of existing data for IMI2 JU projects
Headquarters,
Office
Brussels
26/02/2016 IMI2 Joint
EFPIA
Members of the IMI2 JU Scientific
Meeting of the IMI2 JU Scientific Committee
Undertaking
Committee; IMI2 Joint Undertaking
Programme
Programme Office
Office, Brussels
7/03/2016 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
Trilateral meeting (Commission, EFPIA, IMI2 JU Programme Office) on IMI2 JU
Undertaking
Office
operations
Programme
Office, Brussels
11/03/2016 Teleconference
EFPIA, Johnson & Johnson, IMI2 Joint Undertaking Programme
Preparatory meeting for the IMI2 JU workshop on paediatric clinical research of
Bayer, Lilly, Novonordisk
Office
5 April 2016
14/03/2016 IMI2 Joint
EFPIA
Representatives of the EU Member
Meeting of the IMI2 JU States Representatives Group
Undertaking
States and countries associated to
Programme
the Horizon 2020 programme, IMI2
Office, Brussels
Joint Undertaking Programme Office
22/03/2016 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
8th meeting of the IMI2 JU Governing Board
Undertaking
Office
Programme
Office, Brussels
5/04/2016 Crowne Plaza
EFPIA, several
IMI2 Joint Undertaking Programme
IMI2 JU workshop on paediatric clinical research
Hotel, Brussels
pharmaceuticals companies Office, European Medicines Agency,
several European University and
health research organisations, few
non-European health research
organisations
8/04/2016 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
Negotiation meeting on IMI2 JU call 10 topics
Undertaking
Office
Programme
Office, Brussels
Page 2 of 15
Date
Location
Name of the organisation
Other participants (organisations)
Topics discussed
26/04/2016 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
Follow-up from the IMI2 JU workshop on paediatric clinical research of 5 April
Undertaking
Office
2016
Programme
Office, Brussels
2/05/2016 Teleconference
EFPIA
IMI2 Joint Undertaking Programme
Discussion on how to establish a working group of the IMI2 JU Governing Board
Office
for developing transatlantic alliances
11/05/2016 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
Preparatory meeting for the IMI2 JU Governing Board meeting of 27 June 2016
Undertaking
Office
Programme
Office, Brussels
19/05/2016 Teleconference
EFPIA, Johnson & Johnson
IMI2 Joint Undertaking Programme
Follow-up from the IMI2 JU workshop on paediatric clinical research of 5 April
Office
2016
19/05/2016 European
EFPIA
IMI2 Joint Undertaking Programme
Meeting on future potential IMI2 JU actions on emerging infectious diseases
Commission, DG
Office
Research &
Innovation
24/05/2016 Teleconference
EFPIA
IMI2 Joint Undertaking Programme
Meeting on the operation of IMI2 JU Strategic Governing Groups
Office
25/05/2016 Teleconference
EFPIA, Astrazeneca, GSK,
IMI2 Joint Undertaking Programme
Negotiation meeting for the IMI2 JU guidelines on reporting in-kind
Johnson & Johnson, Lilly,
Office
contributions
Bayer
26/05/2016 Crowne Plaza
EFPIA
Representatives of the EU Member
Meeting of the IMI2 JU States Representatives Group
Hotel, Brussels
States and countries associated to
the Horizon 2020 programme, IMI2
Joint Undertaking Programme Office
26/05/2016 Teleconference
EFPIA
IMI2 Joint Undertaking Programme
9th meeting of the IMI2 JU Governing Board
Office
27/05/2016 IMI2 Joint
EFPIA
Members of the IMI2 JU Scientific
Meeting of the IMI2 JU Scientific Committee
Undertaking
Committee; IMI2 Joint Undertaking
Programme
Programme Office
Office, Brussels
30/05/2016 EFPIA
EFPIA, Johnson & Johnson, IMI2 Joint Undertaking Programme
Meeting on long-term sustainability of results generated by IMI JU projects
Headquarters,
Astrazeneca, GSK, Novartis, Office
Brussels
Bayer
Page 3 of 15
Date
Location
Name of the organisation
Other participants (organisations)
Topics discussed
30/05/2016 EFPIA
EFPIA, Lilly, Bayer
IMI2 Joint Undertaking Programme
Meeting on state of play of in-kind contributions from IMI JU projects
Headquarters,
Office
Brussels
31/05/2016 EFPIA
EFPIA
IMI2 Joint Undertaking Programme
Trilateral meeting (Commission, EFPIA, IMI2 JU Programme Office) on IMI2 JU
Headquarters,
Office
operations
Brussels
3/06/2016 Teleconference
EFPIA
IMI2 Joint Undertaking Programme
Negotiation meeting for the IMI2 JU Annotated Model Grant Agreement, and
Office
the guidelines on reporting in-kind contributions
22/06/2016 Teleconference
EFPIA, Bayer, Johnson &
IMI2 Joint Undertaking Programme
Negotiation meeting on a future potential IMI2 JU call topic for paediatric
Johnson
Office
clinical research
24/06/2016 Teleconference
EFPIA
IMI2 Joint Undertaking Programme
Preparatory meeting for the Governing Board meeting of 27 June 2016
Office
27/06/0016 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
10th meeting of the IMI2 JU Governing Board
Undertaking
Office
Programme
Office, Brussels
18/07/2016 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
Close-out meeting of the IMI JU U-BIOPRED project
Undertaking
Office
Programme
Office, Brussels
6/09/2016 EFPIA
EFPIA
IMI2 Joint Undertaking Programme
Trilateral meeting (Commission, EFPIA, IMI2 JU Programme Office) on IMI2 JU
Headquarters,
Office
operations
Brussels
9/09/2016 EFPIA
EFPIA
none
Bilateral meeting (Commission, EFPIA) on IMI2 JU operations
Headquarters,
Brussels
16/09/2016 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
Meeting on state of play of in-kind contributions from IMI JU projects
Undertaking
Office
Programme
Office, Brussels
19/09/2016 EFPIA
EFPIA
IMI2 Joint Undertaking Programme
Meeting on state of play with IMI2 JU Associated Partners
Headquarters,
Office
Brussels
23/09/2016 Teleconference
EFPIA
IMI2 Joint Undertaking Programme
Negotiation meeting on IMI2 JU call 11 topic
Office
27/09/2016 Teleconference
EFPIA
IMI2 Joint Undertaking Programme
Trilateral meeting (Commission, EFPIA, IMI2 JU Programme Office) on IMI2 JU
Office
operations
Page 4 of 15
Date
Location
Name of the organisation
Other participants (organisations)
Topics discussed
28/09/2016 Crowne Plaza
EFPIA
Several hundreds of stakeholders
IMI2 JU Stakeholder Forum (first part)
Hotel, Brussels
from various European Research
Organisations, IMI2 Joint
Undertaking Programme Office
29/09/2016 Crowne Plaza
EFPIA
Several hundreds of stakeholders
IMI2 JU Stakeholder Forum (second part)
Hotel, Brussels
from various European Research
Organisations, IMI2 Joint
Undertaking Programme Office
30/09/2016 IMI2 Joint
EFPIA
Members of the IMI2 JU Scientific
Meeting of the IMI2 JU Scientific Committee
Undertaking
Committee; IMI2 Joint Undertaking
Programme
Programme Office
Office, Brussels
3/10/2016 Teleconference
EFPIA
IMI2 Joint Undertaking Programme
11th Meeting of the IMI2 JU Governing Board
Office
5/10/2016 European
EFPIA
IMI2 Joint Undertaking Programme
Negotiation meeting on a future potential IMI2 JU call topic for autism research
Commission, DG
Office
Research &
Innovation
7/10/2016 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
Preparatory meeting on IMI2 JU Governing Board meeting of 22 November
Undertaking
Office
2016
Programme
Office, Brussels
17/10/2016 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
Preparatory meeting on IMI2 JU Governing Board meeting of 22 November
Undertaking
Office
2016
Programme
Office, Brussels
17/10/2016 IMI2 Joint
EFPIA, Lilly
IMI2 Joint Undertaking Programme
Meeting on state of play of in-kind contributions from IMI JU projects
Undertaking
Office
Programme
Office, Brussels
28/10/2016 Teleconference
EFPIA
IMI2 Joint Undertaking Programme
Negotiation meeting for the IMI2 JU Annotated Model Grant Agreement
Office
8/11/2016 Teleconference
EFPIA
none
Negotiation meeting for the IMI2 JU Annotated Model Grant Agreement
Page 5 of 15
Date
Location
Name of the organisation
Other participants (organisations)
Topics discussed
10/11/2016 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
Preparatory meeting on IMI2 JU Governing Board meeting of 22 November
Undertaking
Office
2016
Programme
Office, Brussels
15/11/2016 Teleconference
EFPIA. Astrazeneca, Merck IMI2 Joint Undertaking Programme
Negotiation meeting for the IMI2 JU Annotated Model Grant Agreement, and
group, GSK, Novartis,
Office
the guidelines on reporting in-kind contributions
Johnson & Johnson, Bayer,
Lilly,
16/11/2016 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
Trilateral meeting (Commission, EFPIA, IMI2 JU Programme Office) on IMI2 JU
Undertaking
Office
operations
Programme
Office, Brussels
21/11/2016 Stanhope Hotel,
EFPIA
IMI2 Joint Undertaking Programme
Networking Dinner of the IMI2 JU Governing Board
Brussels
Office
22/11/2016 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
12th meeting of the IMI2 JU Governing Board
Undertaking
Office
Programme
Office, Brussels
25/11/2016 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
Negotiation meeting on new IMI2 JU Key Performance Indicators
Undertaking
Office
Programme
Office, Brussels
25/11/2016 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
Close-out meeting of the IMI JU SUMMIT project
Undertaking
Office
Programme
Office, Brussels
12/12/2016 Teleconference
EFPIA
IMI2 Joint Undertaking Programme
Meeting for information on state of play with IMI2 JU call 10
Office
16/12/2016 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
Meeting to discuss future potential IMI2 JU activities on infectious diseases
Undertaking
Office
Programme
Office, Brussels
11/01/2017 Teleconference
Johnson & Johnson
none
Discussion on further work on Ebola disease
11/01/2017 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
Negotiation meeting on new IMI2 JU Key Performance Indicators
Undertaking
Office
Programme
Office, Brussels
Page 6 of 15
Date
Location
Name of the organisation
Other participants (organisations)
Topics discussed
17/01/2017 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
Negotiation meeting on IMI2 JU call 11 topic
Undertaking
Office
Programme
Office, Brussels
19/01/2017 Stanhope Hotel,
EFPIA
IMI2 Joint Undertaking Programme
Informal meeting on IMI2 JU of the Commission representatives in IMI2 JU
Brussels
Office
Governing Board with the new acting Director-General of EFPIA
19/01/2017 Teleconference
EFPIA
Members of the IMI2 JU Strategic
Meeting on future potential IMI2 JU activities on microbiome
Governing Groups,IMI2 Joint
Undertaking Programme Office
23/01/2017 European
EFPIA, Johnson & Johnson
IMI2 Joint Undertaking Programme
Meeting on IMI2 JU on-going activities on the Ebola disease
Commission, DG
Office
Research &
Innovation
27/01/2017 Teleconference
EFPIA
IMI2 Joint Undertaking Programme
Meeting on the revision of the IMI2 JU Manual of Submission
Office
31/01/2017 Teleconference
EFPIA, Ipsen
IMI2 Joint Undertaking Programme
Trilateral meeting (Commission, EFPIA, IMI2 JU Programme Office) on IMI2 JU
Office
operations
6/02/2017 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
Preparatory meeting on IMI2 JU Governing Board meeting of 14 March 2017
Undertaking
Office
Programme
Office, Brussels
10/02/2017 Teleconference
EFPIA
Members of the IMI2 JU Scientific
Meeting of the IMI2 JU Scientific Committee
Committee; IMI2 Joint Undertaking
Programme Office
14/02/2017 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
Preparatory meeting for the IMI2 JU Regulatory summit 2017 on 5 December
Undertaking
Office
2017
Programme
Office, Brussels
24/02/2017 European
EFPIA
IMI2 Joint Undertaking Programme
Meeting on IMI2 JU Annotated Model Grant Agreement, and other legal issues
Commission, DG
Office
regarding EFPIA participation in IMI2 JU projects
Research &
Innovation
Page 7 of 15
Date
Location
Name of the organisation
Other participants (organisations)
Topics discussed
9/03/2017 IMI2 Joint
EFPIA
Representatives of the EU Member
Meeting of the IMI2 JU States Representatives Group
Undertaking
States and countries associated to
Programme
the Horizon 2020 programme, IMI2
Office, Brussels
Joint Undertaking Programme Office
14/03/2017 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
13th meeting of the IMI2 JU Governing Board
Undertaking
Office
Programme
Office, Brussels
17/03/2017 EFPIA
EFPIA
IMI2 Joint Undertaking Programme
Negotiation meeting on potential IMI2 JU follow-up activities to the European
Headquarters,
Office
Lead Factory
Brussels
20/03/2017 IMI2 Joint
EFPIA
Members of the IMI2 JU Scientific
Meeting of the IMI2 JU Scientific Committee
Undertaking
Committee; IMI2 Joint Undertaking
Programme
Programme Office
Office, Brussels
23/03/2017 Teleconference
EFPIA
IMI2 Joint Undertaking Programme
Meeting on the IMI2 JU process for proposals evaluation
Office
24/03/2017 European
EFPIA
IMI2 Joint Undertaking Programme
Meeting on the IMI2 JU process for proposals evaluation
Commission, DG
Office
Research &
Innovation
30/03/2017 Teleconference
Johnson & Johnson
none
Discussion on further work on Ebola disease
31/03/2017 European
Johnson & Johnson
Staff of Directorate E of DG Research Screening of the documentary "Unseen enemy" on infectious diseases
Commission, DG
and Innovation, IMI2 Joint
Research &
Undertaking Programme Office
Innovation
11/04/2017 Teleconference
EFPIA
IMI2 Joint Undertaking Programme
Discussin on collaboration between the IMI2 JU and the Coalition for Epidemic
Office, CEPI Office
Preparedness Innovations (CEPI)
4/05/2017 Teleconference
EFPIA
IMI2 Joint Undertaking Programme
Preparatory meeting of the IMI2 JU Governing Board meeting of 27 June 2017
Office
5/05/2017 Teleconference
EFPIA
Members of the IMI2 JU Scientific
Meeting of the IMI2 JU Scientific Committee
Committee; IMI2 Joint Undertaking
Programme Office
Page 8 of 15
Date
Location
Name of the organisation
Other participants (organisations)
Topics discussed
18/05/2017 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
Preparatory meeting for the IMI2 JU Governing Board meeting of 27 June
Undertaking
Office
Programme
Office, Brussels
18/05/2017 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
Meeting on the IMI2 JU process for proposals evaluation
Undertaking
Office
Programme
Office, Brussels
22/05/2017 European
EFPIA
none
Informal meeting on IMI2 JU of Commission representatives in IMI2 JU
Commission, DG
Governing Board with the new Director-General of EFPIA
Research &
Innovation
7/06/2017 Teleconference
EFPIA
IMI2 Joint Undertaking Programme
14th meeting of the IMI2 JU Governing Board
Office
8/06/2017 IMI2 Joint
EFPIA
Representatives of the EU Member
Meeting of the IMI2 JU States Representatives Group
Undertaking
States and countries associated to
Programme
the Horizon 2020 programme, IMI2
Office, Brussels
Joint Undertaking Programme Office
9/06/2017 IMI2 Joint
EFPIA
Members of the IMI2 JU Scientific
Meeting of the IMI2 JU Scientific Committee
Undertaking
Committee; IMI2 Joint Undertaking
Programme
Programme Office
Office, Brussels
12/06/2017 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
Close-out meeting of the IMI JU RAPP-ID project
Undertaking
Office
Programme
Office, Brussels
15/06/2017 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
Meeting on patient engagement into IMI2 JU activities
Undertaking
Office
Programme
Office, Brussels
23/06/2017 European
Johnson & Johnson
IMI2 Joint Undertaking Programme
Meeting on IMI2 JU on-going activities on the Ebola disease
Commission, DG
Office
Research and
Innovation
Page 9 of 15
Date
Location
Name of the organisation
Other participants (organisations)
Topics discussed
27/06/2017 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
15th meeting of the IMI2 JU Governing Board
Undertaking
Office
Programme
Office, Brussels
6/07/2017 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
Trilateral meeting (Commission, EFPIA, IMI2 JU Programme Office) on IMI2 JU
Undertaking
Office
operations
Programme
Office, Brussels
11/07/2017 EFPIA
EFPIA, Astrazeneca, Johnson IMI2 Joint Undertaking Programme
Negotiation meeting for the IMI2 JU Annotated Model Grant Agreement
Headquarters,
& Johnson, Novartis
Office
Brussels
18/07/2017 Teleconference
EFPIA, Johnson & Johnson, IMI2 Joint Undertaking Programme
Meeting on future potential IMI2 JU topic for Anti-Microbial Resistance
Novartis, Pfizer, Merck
Office
Group, Astrazeneca,
7/09/2017 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
Meeting for the development of a brochure presenting IMI JU results
Undertaking
Office
Programme
Office, Brussels
8/09/2017 Teleconference
EFPIA
Members of the IMI2 JU Scientific
Meeting of the IMI2 JU Scientific Committee
Committee; IMI2 Joint Undertaking
Programme Office
8/09/2017 Teleconference
EFPIA
IMI2 Joint Undertaking Programme
Trilateral meeting (Commission, EFPIA, IMI2 JU Programme Office) on IMI2 JU
Office
operations
12/09/2017 Teleconference
EFPIA
IMI2 Joint Undertaking Programme
Negotiation meeting on IMI2 JU call 13 topics
Office
19/09/2017 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
Negotiation meeting on future potential IMI2 JU topic for Anti-Microbial
Undertaking
Office
Resistance
Programme
Office, Brussels
19/09/2017 Dublin, Ireland
EFPIA
Representatives of the EU Member
Meeting of the IMI2 JU States Representatives Group
States and countries associated to
the Horizon 2020 programme, IMI2
Joint Undertaking Programme Office
Page 10 of 15
Date
Location
Name of the organisation
Other participants (organisations)
Topics discussed
21/09/2017 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
Preparatory meeting for the informal meeting of the IMI2 JU Governing Board
Undertaking
Office
of 28 September 2017
Programme
Office, Brussels
25/09/2017 Teleconference
EFPIA
IMI2 Joint Undertaking Programme
Negotiation meeting on new IMI2 JU Key Performance Indicators
Office
28/09/2017 Teleconference
EFPIA
IMI2 Joint Undertaking Programme
Informal meeting of the IMI2 JU Governing Board
Office
5/10/2017 EFPIA
EFPIA, Johnson & Johnson, IMI2 Joint Undertaking Programme
Negotiation meeting on future potential IMI2 JU topic for Anti-Microbial
Headquarters,
Sanofi, GSK
Office
Resistance
Brussels
6/10/2017 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
Preparatory meeting for the IMI2 JU Governing Board meeting of 10 November
Undertaking
Office
2017
Programme
Office, Brussels
16/10/2017 EFPIA
EFPIA
IMI2 Joint Undertaking Programme
Meeting on new potential IMI2 JU cross-industrial collaborations
Headquarters,
Office
Brussels
18/10/2017 Crowne Plaza
EFPIA
Several hundreds of stakeholders
IMI2 JU Stakeholder Forum (first part)
Hotel, Brussels
from various European Research
Organisations, IMI2 Joint
Undertaking Programme Office
19/10/2017 Crowne Plaza
EFPIA
Several hundreds of stakeholders
IMI2 JU Stakeholder Forum (second part)
Hotel, Brussels
from various European Research
Organisations, IMI2 Joint
Undertaking Programme Office
19/10/2018 European
EFPIA
European Commission Directorate-
Meeting for mapping initiatives in the area of health data for pharmaceuticals
Commission,
General Health and Food Safety
Directorate-
General Health
and Food Safety
20/10/2017 IMI2 Joint
EFPIA
Members of the IMI2 JU Scientific
Meeting of the IMI2 JU Scientific Committee
Undertaking
Committee; IMI2 Joint Undertaking
Programme
Programme Office
Office, Brussels
Page 11 of 15
Date
Location
Name of the organisation
Other participants (organisations)
Topics discussed
27/10/2017 Teleconference
EFPIA, Johnson & Johnson, IMI2 Joint Undertaking Programme
Negotiation meeting on future potential IMI2 JU topic for Anti-Microbial
Sanofi, GSK
Office
Resistance
30/10/2017 Teleconference
EFPIA
IMI2 Joint Undertaking Programme
Preparatory meeting for the IMI2 JU Governing Board meeting of 10 November
Office
2017
7/11/2017 BIO Europe
EBE
none
Discussion on Supplementary Protection Certificates
Conference
10/11/2017 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
16th meeting of the IMI2 JU Governing Board
Undertaking
Office
Programme
Office, Brussels
21/11/2017 Teleconference
EFPIA, Johnson & Johnson, IMI2 Joint Undertaking Programme
Negotiation meeting on IMI2 JU call 14 topics
Novartis
Office
24/11/2017 Teleconference
EFPIA, Johnson & Johnson, IMI2 Joint Undertaking Programme
Negotiation meeting on future potential IMI2 JU topic for Anti-Microbial
Sanofi, GSK
Office
Resistance
29/11/2017 Teleconference
EFPIA
IMI2 Joint Undertaking Programme
Negotiation meeting on future potential IMI2 JU topics for follow-up activities
Office, EMA, SC Members
5/12/2017 Crown Plaza
EFPIA
Representatives of the European
IMI2 JU Regulatory summit 2017 on 5 December 2017
Hotel, Brussels
Medicines Agency, representatives of
EU national medicines regulatory
agencies, representatives of the US
Federal Drug Administration,
representatives of EU national
medicines regulatory agencies, IMI2
Joint Undertaking Programme Office
7/12/2017 Teleconference
EFPIA
IMI2 Joint Undertaking Programme
Trilateral meeting (Commission, EFPIA, IMI2 JU Programme Office) on IMI2 JU
Office
operations
14/12/2017 European
EFPIA
none
Meeting between the Director-General for Research and Innovation and the
Commission,
EFPIA Director-General to discuss on Framework Programme 9 (FP9) and on
Directorate-
IMI2 JU
General Research
and Innovation
Page 12 of 15
Date
Location
Name of the organisation
Other participants (organisations)
Topics discussed
14/12/2017 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
Close-out meeting of the IMI JU PREDECT project
Undertaking
Office
Programme
Office, Brussels
14/12/2017 Teleconference
EFPIA, Johnson & Johnson, IMI2 Joint Undertaking Programme
Negotiation meeting on future potential IMI2 JU topic for Anti-Microbial
Sanofi, GSK
Office
Resistance
17/12/2017 European
EFPIA, EBE
Meeting on ‘incentives for the development of pharmaceuticals’ in particular
Commission,
Supplementary Protection Certificates (SPC)
Directorate-
General Research
and Innovation
15/12/2017 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
17th meeting of the IMI2 JU Governing Board
Undertaking
Office
Programme
Office, Brussels
18/12/2017 European
EBE, EFPIA
none
Discussion on supplementary protection certificates
Commission,
Directorate-
General Research
and Innovation
17/01/2018 IMI2 Joint
EFPIA
Representatives of the EU Member
Meeting of the IMI2 JU States Representatives Group
Undertaking
States and countries associated to
Programme
the Horizon 2020 programme, IMI2
Office, Brussels
Joint Undertaking Programme Office
19/01/2018 European
EFPIA
none
Meeting with the Director-General of EFPIA on future potential IMI2 JU
Commission,
activities in 2019 and 2020
Directorate-
General Research
and Innovation
Page 13 of 15
Date
Location
Name of the organisation
Other participants (organisations)
Topics discussed
23/01/2018 European
EFPIA, GSK, Sanofi
IMI2 Joint Undertaking Programme
Meeting on future potential IMI2 JU activities on vaccines and infectious
Commission,
Office
diseases
Directorate-
General Research
and Innovation
23/01/2018 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
Trilateral meeting (Commission, EFPIA, IMI2 JU Programme Office) on IMI2 JU
Undertaking
Office
operations
Programme
Office, Brussels
25/01/2018 Teleconference
EFPIA
IMI2 Joint Undertaking Programme
Negotiation meeting for the IMI2 JU Annotated Model Grant Agreement, and
Office
the guidelines on reporting in-kind contributions
25/01/2018 Teleconference
EFPIA, GSK
IMI2 Joint Undertaking Programme
Negotiation meeting on future potential IMI2 JU topic for Anti-Microbial
Office
Resistance
26/01/2018 Teleconference
EFPIA
Members of the IMI2 JU Scientific
Meeting of the IMI2 JU Scientific Committee
Committee; IMI2 Joint Undertaking
Programme Office
30/01/2018 IMI2 Joint
EFPIA, Sanofi, Novartis,
IMI2 Joint Undertaking Programme
Meeting on IMI2 JU call 12 results
Undertaking
Pfizer, Johnson & Johnson, Office
Programme
Cellulardynamics, GSK,
Office, Brussels
Novonordisk, Fujifilm
31/01/2018 Teleconference
EFPIA
IMI2 Joint Undertaking Programme
Trilateral meeting (Commission, EFPIA, IMI2 JU Programme Office) on IMI2 JU
Office
operations
5/02/2018 EFPIA
EFPIA
IMI2 Joint Undertaking Programme
Trilateral meeting (Commission, EFPIA, IMI2 JU Programme Office) on IMI2 JU
Headquarters,
Office
operations
Brussels
15/02/2018 EFPIA
EFPIA
IMI2 Joint Undertaking Programme
Coordination meeting for the events on IMI 10th anniversary
Headquarters,
Office
Brussels
20/02/2018 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
Trilateral meeting (Commission, EFPIA, IMI2 JU Programme Office) on IMI2 JU
Undertaking
Office
operations
Programme
Office, Brussels
22/02/2018 Teleconference
EFPIA
IMI2 Joint Undertaking Programme
Negotiation meeting on future potential IMI2 JU topics for follow-up activities
Office
Page 14 of 15
Date
Location
Name of the organisation
Other participants (organisations)
Topics discussed
22/02/2018 Teleconference
EFPIA, Johnson & Johnson, IMI2 Joint Undertaking Programme
Negotiation meeting on future potential IMI2 JU topic for Anti-Microbial
Sanofi, GSK
Office
Resistance
23/02/2018 IMI2 Joint
EFPIA
Members of the IMI2 JU Scientific
Meeting of the IMI2 JU Scientific Committee
Undertaking
Committee; IMI2 Joint Undertaking
Programme
Programme Office
Office, Brussels
1/03/2018 European
EFPA
MedTechEurope
Meeting on the application of the GDPR and specifically the questions on the
Commission, DG
guidance of the Article 29 working party on consent
Research and
Innovation
26/02/2018 Teleconference
EFPIA, Johnson & Johnson, IMI2 Joint Undertaking Programme
Negotiation meeting on future potential IMI2 JU topic for Anti-Microbial
Sanofi, GSK
Office
Resistance
5/03/2018 EFPIA
EFPIA
IMI2 Joint Undertaking Programme
Trilateral meeting (Commission, EFPIA, IMI2 JU Programme Office) on IMI2 JU
Headquarters,
Office
operations
Brussels
9/03/2018 Teleconference
EFPIA
IMI2 Joint Undertaking Programme
Preparatory meeting for the IMI2 JU Governing Board meeting of 20 March
Office
2018
9/03/2018 Teleconference
EFPIA
IMI2 Joint Undertaking Programme
18th meeting of the IMI2 JU Governing Board
Office
13/03/2018 IMI2 Joint
EFPIA
IMI2 Joint Undertaking Programme
Coordination meeting for the events on IMI 10th anniversary
Undertaking
Office
Programme
Office, Brussels
Page 15 of 15